Stephanie Bernstein
Hematology & Oncology · Winchester, MANPI 1396814265
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $622,245 of the $622,288 with a category attached, or 100.0%. Acerta Pharma LLC accounts for 78.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $236,110 and has fallen 95.1% since, to $11,483 in 2025. Among hematology & oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $6415.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acerta Pharma LLC$487K
- Astrazeneca UK Limited$111K
- Beigene, Ltd.$16K
- Merck$8K
- AstraZeneca$43
Across 77 payments — averaging $6394.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$188K
- Acerta Pharma LLC$118K
- AbbVie$74K
- E.r. Squibb & Sons, L.L.C.$74K
- Beone Medicines Ltd.$17K
- Beigene (suzhou) Co., Ltd.$8K
- plus $12K from 4 others
What the payments were for
- Consulting fees$622,245100%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acerta Pharma LLC | 52 | $486,850 |
| Astrazeneca UK Limited | 29 | $111,155 |
| Beigene, Ltd. | 6 | $16,240 |
| Merck | 9 | $8,000 |
| AstraZeneca | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$622,288 in reported general payments places this provider in the 95th percentile of 374 hematology & oncology providers in Massachusetts.
Other hematology & oncology in Winchester
- David ScaddenBoston$2.6M
- Sara TolaneyBoston$799K
- Matthew DavidsBoston$693K
- Julio HajdenbergBoston$583K
- Paul RichardsonBoston$523K
- Seth WanderBoston$464K
- Corey CutlerBoston$454K
- Hanny Al-SamkariBoston$412K
- Karl DsilvaPeabody$383K
- Rupal BhattBoston$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.